MedPath

OPTIRAY 350 (ULTRAJECT)

OPTIRAY 350 (ULTRAJECT)

Dormant
DIN Number

02079992

Drug Class

Human

Market Date

Dec 31, 1996

Company
HC

LIEBEL-FLARSHEIM COMPANY LLC

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02079992
AIG Number0131317001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
V08AB07 IOVERSOL
Product Specifications
Dosage FormSolution
Route of AdministrationIntravascular
AHFS Classification36:68.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

IOVERSOLActive
Strength: 74 % / W/V
Monograph: IOVERSOL

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.